Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Stanley R. Ress"'
Autor:
Richard Pine, Michael D. Weiden, Stanley R. Ress, Yoshihiko Hoshino, Ilana Belitskaya-Levy, Jeffrey A. Gold, B. Raju, Anna Nolan, William N. Rom, Rod Dawson, Stuart M. Brown, Rany Condos
Publikováno v:
Tuberculosis. 88:39-51
The host response to Mycobacterium tuberculosis includes macrophage activation, inflammation with increased immune effector cells, tissue necrosis, and cavity formation, and fibrosis, distortion, and bronchiectasis. To evaluate the molecular basis of
Autor:
Nazma Mansoor, Rose Ann Murray, E. Jane Hughes, Sebastian Gelderbloem, Gregory D. Hussey, Virginia Davids, Anthony Hawkridge, Willem A. Hanekom, Hoyam Gamieldien, Jorge H. Soler, Stanley R. Ress, Gilla Kaplan
Publikováno v:
The Journal of Infectious Diseases. 193:531-536
Vaccination with Mycobacterium bovis bacille Calmette-Guerin (BCG) has variable efficacy in preventing tuberculosis. Both BCG strain and route of administration have been implicated in determining efficacy; however, these variables are not considered
Autor:
Robert N. Davidson, Simon J. Waddell, Lynn Semple, Anna Goodsall, Robert J. Wilkinson, Elisabeth H. Schölvinck, Brian J. Sheehan, Katalin A. Wilkinson, Alick C Stephens, Mark P. Nicol, Suzanne T. Anderson, Beate Kampmann, David A. Relman, Cheryl Hemingway, Paul R. Langford, Michael Levin, Stanley R. Ress, Martin L. Hibberd
Publikováno v:
Journal of Clinical Investigation. 115:2480-2488
Genetic defects in the IFN-gamma response pathway cause unique susceptibility to intracellular pathogens, particularly mycobacteria, but are rare and do not explain mycobacterial disease in the majority of affected patients. We postulated that acquir
Autor:
Stanley R. Ress
Publikováno v:
SAMJ: South African Medical Journal, Volume: 104, Issue: 11, Pages: 791-792, Published: NOV 2014
Adults presenting with recurrent infections require an approach that allows exclusion of underlying immunodeficiency. While secondary causes of immunodeficiency are the most common, primary immunodeficiency disease (PID) may present for the first tim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ede2898443e8ee501d25032d8e1e46f8
http://www.scielo.org.za/scielo.php?script=sci_arttext&pid=S0256-95742014001100031&lng=en&tlng=en
http://www.scielo.org.za/scielo.php?script=sci_arttext&pid=S0256-95742014001100031&lng=en&tlng=en
Publikováno v:
Immunology. 102:146-156
Despite strong evidence for CD8+ T-cell function in murine mycobacterial infections, their corresponding role in human tuberculosis has proven more difficult to demonstrate. We have evaluated the human macrophage (Mphi) cell line U937 as an in vitro
Autor:
Gilla Kaplan, Virginia Davids, Willem A. Hanekom, Marcia Watkins, Stanley R. Ress, Patricia L. Semple, Alan M. Krensky
Publikováno v:
Clinical and Developmental Immunology, Vol 2011 (2011)
Clinical and Developmental Immunology
Clinical and Developmental Immunology
Background. While vaccination at birth withMycobacterium bovisBacilli Calmette-Guérin (BCG) protects against severe childhood tuberculosis, there is no consensus as to which components of the BCG-induced immune response mediate this protection. Howe
Autor:
Clint Brauns, Chi-Hong Tseng, Rod Dawson, Maryann L. Huie, William N. Rom, Doris B. Tse, Michael D. Weiden, Eric D. Bateman, Stanley R. Ress, Rany Condos, Yoshihiko Hoshino
Publikováno v:
PLoS ONE
PLoS ONE, Vol 4, Iss 9, p e6984 (2009)
PLoS One
PLoS ONE, Vol 4, Iss 9, p e6984 (2009)
PLoS One
BACKGROUND Current treatment regimens for pulmonary tuberculosis require at least 6 months of therapy. Immune adjuvant therapy with recombinant interferon-gamma1b (rIFN-gammab) may reduce pulmonary inflammation and reduce the period of infectivity by
Publikováno v:
Tuberculosis (Edinburgh, Scotland). 87(6)
Factors that relate to medium-term outcome in patients with pulmonary tuberculosis (PTB) who have completed the 2-month intensive phase of treatment are incompletely understood. The relationship between in vitro production of interferon-gamma (IFN-ga
Autor:
Rose Ann Murray, Gilla Kaplan, Ronel Sheperd, Anthony Hawkridge, Gregory D. Hussey, Jorge H. Soler, Stanley R. Ress, Lesley Workman, Sebastian Gelderbloem, Virginia Davids, Willem A. Hanekom
Publikováno v:
Clinical and vaccine immunology : CVI. 14(2)
In 10-week-old infants vaccinated at birth with JapaneseMycobacterium bovisBCG, the number of dermal needle penetrations correlated positively with frequency of proliferating CD4+T cells in whole blood following BCG stimulation for 6 days but did not
Autor:
Stanley R. Ress, Nazma Mansoor, Maushumi Mavinkurve, Mzwandile Sidibana, Patrick A. J. Haslett, Anthony Hawkridge, Sebastian Gelderbloem, Virginia Davids, Hoyam Gamieldien, Marcia Watkins, Megan Mendillo, Willem A. Hanekom, Jane Hughes, Rose Ann Murray, Gilla Kaplan, Gregory D. Hussey
Publikováno v:
Journal of immunological methods. 291(1-2)
We optimized a whole blood intracellular cytokine assay to quantitate the frequency of specific CD4+ and CD8+ T cells in small volumes of whole blood from infants from developing countries. The assay is performed in two steps. First, whole blood is s